GeneDx Holdings Corp. (WGS) insider trading

By person

12 insiders · 139 transactions

15.9×

Katherine Stueland holds 15.9 times base salary in stock. $11.43M of shares against $715.87K in salary for 2025.

Salary from the company's own proxy. The shares are what Katherine Stueland last reported holding, valued at $99.00, the price Class A Common Stock was last bought or sold at on the open market here, on 16 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Keith A. Meister

Director

$74.03M (29)

—

+$74.03M

4,808,275

16.12%

$476.00M

+93.8%

Casdin Capital, LLC entity

Director

$32.57M (5)

—

+$32.57M

3,707,164

12.43%

$366.99M

+5.7%

Katherine Stueland

Chief Executive Officer

—

$11.21M (37) scheduled

−$11.21M

115,476

0.3872%

$11.43M

+9.5%

Joshua Ruch

Director

—

$6.09M (15)

−$6.09M

153,382

0.5143%

$15.18M

−7.6%

Kevin Feeley

Chief Financial Officer

—

$3.30M (41) scheduled

−$3.30M

44,945

0.1507%

$4.45M

−50.0%

Bryan Dechairo

Chief Operating Officer

—

$850.56K (12) scheduled

−$850.56K

0.0000%

$0.00

—

School Of Medicine At Mount Sinai Icahn

10% owner

—

2,719,692

9.12%

$269.24M

−5.1%

Jason Ryan

Director

—

118,764

0.3982%

$11.76M

−64.0%

Richard C Pfenniger Jr

Director

—

45,082

0.1512%

$4.46M

+63.0%

Emily M. Leproust

Director

—

24,852

0.0833%

$2.46M

+197.6%

Eli Casdin

Director

—

24,093

0.0808%

$2.39M

+217.3%

Thomas Fuchs

Director

—

1,146

0.0038%

$113.45K

—

GeneDx Holdings Corp.

What the insiders did Net buying

By person